[1] Struyf S, Proost P, Lenaerts JP, et al. Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1[J]. Blood, 2001,15,97(8):2197-2204. [2] Struyf S, Stoops G, Van Coillie E, et al. Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants[J]. Biochemistry, 2001,40(39):11715-11722. [3] Van Damme J, Proost P, Stoops S. REGAKINE-1[P]. WO02066510A2,2002-08-29. [4] Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking[J]. Am J Physiol Regulatory Integrative Comp Physiol,2002,283(1):7-28. [5] Stein JV, Nombela-Arrieta C. Chemokine control of lymphocyte trafficking:a general overview[J].Immunology,2005,116(1):1-12. [6] Kunkel SL. Through the looking glass: the diverse in vivo activities of chemokine[J]. J.Clin.Invest, 1999,104(10):1333-1334. [7] Zlotnil A, Yoshie O. Chemokines:a new classification system and their role in immunity[J]. 2000,12(2):121-127. [8] Gouwy M, Struyf S, Mahieu F, et al. The unique property of the CC chemokine regakine-1 to synergize with other plasma-derived inflammatory mediators in neutrophil chemotaxis does not reside in its NH2-terminal structure. [J]. Mol Pharmacol, 2002,62(1):173-80. [9] Struyf S, Gouwy M, Dillen C, et al. Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue[J]. Eur J Immunol. 2005,35(5):1583-1591. [10] Gouwy M, Struyf S, Catusse J, et al. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration[J]. J Leukoc Biol, 2004,76(1):185-194.
|